Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C22H21F2N4O5P |
| Molecular Weight | 490.3965 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C[C@H](CC1=CC=CC=C1)OP(O)(O)=O)C(=O)C2=CC(=CN=C2)C#CC3=CN(N=C3)C(F)F
InChI
InChIKey=AJSWMXIMACDPCV-FQEVSTJZSA-N
InChI=1S/C22H21F2N4O5P/c1-27(15-20(33-34(30,31)32)10-16-5-3-2-4-6-16)21(29)19-9-17(11-25-13-19)7-8-18-12-26-28(14-18)22(23)24/h2-6,9,11-14,20,22H,10,15H2,1H3,(H2,30,31,32)/t20-/m0/s1
| Molecular Formula | C22H21F2N4O5P |
| Molecular Weight | 490.3965 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 12:44:01 GMT 2025
by
admin
on
Wed Apr 02 12:44:01 GMT 2025
|
| Record UNII |
6GA6XSX5SL
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
13384
Created by
admin on Wed Apr 02 12:44:01 GMT 2025 , Edited by admin on Wed Apr 02 12:44:01 GMT 2025
|
PRIMARY | |||
|
167466532
Created by
admin on Wed Apr 02 12:44:01 GMT 2025 , Edited by admin on Wed Apr 02 12:44:01 GMT 2025
|
PRIMARY | |||
|
6GA6XSX5SL
Created by
admin on Wed Apr 02 12:44:01 GMT 2025 , Edited by admin on Wed Apr 02 12:44:01 GMT 2025
|
PRIMARY | |||
|
2905377-00-4
Created by
admin on Wed Apr 02 12:44:01 GMT 2025 , Edited by admin on Wed Apr 02 12:44:01 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
PRECLINICAL
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
